SENSEX    73738.45       89.83    |    NIFTY    22368       31.60 FAQ    |    Feedback
EQUITIES
DERIVATIVES
IPO
Gainers & Losers Value & Volume Toppers 52 Weeks High/Low Advances & Declines
New High-Low
Pre-Session Mid-Session End-Session Other Markets Market Beat Stock Alert
Hot Pursuit Foreign Markets Economy News Corporate News Corporate Results
Detailed Quotes Board of Directors Balance Sheet Profit & Loss Quarterly Results Historical Price
Financial Ratios Company Background Technical Chart
Announcements Book Closure Board Meetings Bonus Issues Rights Issues
De-Listed Shares Name Change Split of Face Value Market Turnover
FII Investments MF Investments ADR Prices World Indices
Forthcoming IPOs
Open IPOs
Closed IPOs
New Listing
Basis Of Allotment Draft Prospectus New Issue Monitor
Get Quotes
Gainers
Losers
Value Toppers Advances & Declines Ticker Spot
Ticker Futures Closing Price Technical Chart Commodity News MCX Currency Futures
Get Quotes NIFTY Futures Top Traded Value Top Quantity Most Active Contracts
FII Statistics Daily Settlement Price List of Underlyings Put Call Ratio Derivative Summary
All Index Futures Top Gainers Top Losers Most Active Put Most Active Call
Highest in OI Lowest in OI Increase in OI Decrease in OI
Stock Alert
Overall view of all the recent market developments which will help in your investment decisions
RITES may rise on bagging additional contract from Indian Railways
19-Sep-18   08:19 Hrs IST

RITES said it received additional turnkey contract work worth Rs 436 crore from the Indian Railways. This contract is in addition to existing project for setting up of a wagon workshop at Dalmianagar for which the initial contract cost was worth Rs 89 crore. The announcement was made after market hours yesterday, 18 September 2018.

KIOCL said its board approved buyback of 1.25 crore shares (1.98% of paid up capital) at Rs 170 per share for an aggregate consideration of Rs 214 crore. The record date for the buyback is 1 October 2018. The announcement was made after market hours yesterday, 18 September 2018.

Sun Pharmaceutical Industries announced that Almirall has received the European Commission (EC) approval for Ilumetri (tildrakizumab) for the treatment of adults with moderate-to-severe chronic plaque psoriasis who are candidates for systemic therapy. As indicated by Almirall, roll out of Ilumetri in Europe will start in the next few weeks. In July 2016, Sun Pharma out-licensed tildrakizumab to Almirall, for the development and commercialization of the product for psoriasis in Europe. The announcement was made after market hours yesterday, 18 September 2018.

ICICI Prudential Life Insurance Company, one of the largest private sector life insurance company in India, and Saraswat Co-operative Bank (Saraswat Bank), a century old and India's largest urban co-operative bank, have come together to offer life insurance products ranging from protection to wealth creation. Through this partnership, over 280 Saraswat Bank branches in Maharashtra, Goa, Gujarat, Delhi, Madhya Pradesh and Karnataka will offer the entire range of protection and savings products of ICICI Prudential Life. The announcement was made after market hours yesterday, 18 September 2018.

ICICI Bank clarified after market hours yesterday, 18 September 2018, that it has not filed any application for settlement but only a response to the show-cause notice has been submitted to Securities and Exchange Board of India (Sebi). The clarification was issued after Sebi chairman reportedly stated that ICICI Bank filed a consent petition with Sebi.

Powered by Capital Market - Live News

MARKETS
TODAY'S MARKET SECTOR
BSE NSE
Currencies
Currency EUR GBP INR USD
Europe (EUR) 1.00 0.86 88.89 1.07
United Kingdom (GBP) 1.16 1.00 103.18 1.24
India (INR) 0.01 0.01 1.00 0.01
United States (USD) 0.94 0.81 83.42 1.00
Market News << ALL News
  23-Apr-2024, (05:10 )  Tata Consumer Q4 PAT..
  23-Apr-2024, (04:00 )  NBCC rallies as new ..
  23-Apr-2024, (03:27 )  Artson Engineering h..
  23-Apr-2024, (03:25 )  Aarti Drugs Baddi fa..
 Commodities << ALL Commodities
   Attention Investor: Prevent unauthorized transactions in your trading / Demat account : Update your mobile number / e mail ids with your stock broker / deposit." | "No need to issue cheques by investors while subscribing to IPO.Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account." | "KYC is one time exercise while dealing in securities markets- once KYC is done through a SEBI registered intermediary(broker, DP, Mutual Fund etc.) you need not undergo the same process again when you approach another intermediary."
   Disclaimer   |   BSE Disclosure  |  Privacy Policy   |   Investor Protection   |    Inactive Account   |  Vernacular Language: NSE | BSE   |   Feedback   |    PMLA Policy   |   Risk Management Policy   |   Insider Trading   |   Investor Grivenances   |   Investor Complaints   |   Investor Charter   |   Rules And Regulations   |   Broker Norms   |   Terms of Use    Policies & Procedures   |   Risk Disclosure   |   Do & Don’ts   |   Rights & Obligations
  
SEBI Registration No : INZ000267132   |   BSE Clearing No : 333   
   Copyright © 2011 All rights reserved by Jaysukhlal Jagjivan Stock Broking Pvt.Ltd Designed, Developed & Powered By CMOTS INFOTECH (ISO 9001:2015 certified)